Pre-Open Stock Movers 11/24: (OCUP) (PSTG) (HPQ) Higher; (JWN) (GPS) (OTLK) Lower (more...)

November 24, 2021 9:19 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Pre-Open Stock Movers:

Ocuphire (NASDAQ: OCUP) 50% HIGHER; H.C. Wainwright initiates coverage with a Buy rating and a price target of $26.00.

Nordstrom (NYSE: JWN) 24.8% LOWER; reported Q3 EPS of $0.39, $0.13 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.52 billion. The Company is reaffirming the following financial expectations for fiscal 2021.

Gap, Inc. (NYSE: GPS) 22% LOWER; reported Q3 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $3.94 billion versus the consensus estimate of $4.47 billion. Gap, Inc. sees FY2021 EPS of $1.25-$1.40, versus the consensus of $2.20.

Outlook Therapeutics, Inc. (Nasdaq: OTLK) 21.1% LOWER; announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 40,000,000 shares of common stock of Outlook Therapeutics, at a price to the public of $1.25 per share, less underwriting discounts and commissions.

Kura Oncology, Inc. (Nasdaq: KURA) 18.7% LOWER; announced that the U.S. Food and Drug Administration (FDA) has placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold. The partial clinical hold was initiated following the Companys recent report to the FDA of a Grade 5 serious adverse event (patient death) potentially associated with differentiation syndrome, a known adverse event related to differentiating agents in the treatment of AML.

Autodesk (NASDAQ: ADSK) 14.2% LOWER; reported Q3 EPS of $1.33, $0.07 better than the analyst estimate of $1.26. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.12 billion. Autodesk sees Q4 2022 EPS of $1.41-$1.47, versus the consensus of $1.46. Autodesk sees Q4 2022 revenue of $1.185-1.2 billion, versus the consensus of $1.2 billion.

Pure Storage, Inc. (NYSE: PSTG) 12.7% HIGHER; reported Q3 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $562.7 million versus the consensus estimate of $530.83 million. Pure Storage, Inc. sees Q4 2022 revenue of $630 million, versus the consensus of $602.24 million. Pure Storage, Inc. sees FY2022 revenue of $2.1 billion, versus the consensus of $2.04 billion.

Anaplan, Inc. (NYSE: PLAN) 12.6% LOWER; reported Q3 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $155.3 million versus the consensus estimate of $146.29 million. Anaplan, Inc. sees Q4 2022 revenue of $154-155 million, versus the consensus of $152.9 million. Anaplan, Inc. sees FY2022 revenue of $583.5-584.5 million, versus the consensus of $573.5 million.

HP Inc. (NYSE: HPQ) 8.2% HIGHER; reported Q4 EPS of $0.94, $0.05 better than the analyst estimate of $0.89. Revenue for the quarter came in at $16.68 billion versus the consensus estimate of $15.43 billion. HP Inc. sees FY2022 EPS of $4.07-$4.27, versus the consensus of $3.73.

Synlogic Inc. (NASDAQ: SYBX) 7.9% HIGHER; Oppenheimer upgraded from Perform to Outperform with a price target of $7.00.

Nutanix (NASDAQ: NTNX) 5% HIGHER; reported Q1 EPS of ($0.22), $0.12 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $378.5 million versus the consensus estimate of $367.04 million. Nutanix sees Q2 2022 revenue of $400-410 million, versus the consensus of $399.94 million. Nutanix sees FY2022 revenue of $1.615-1.63 billion, versus the consensus of $1.6 billion.

Dell Technologies (NYSE: DELL) 1.5% HIGHER; reported Q3 EPS of $2.37, $0.28 better than the analyst estimate of $2.09. Revenue for the quarter came in at $28.4 billion versus the consensus estimate of $27.01 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Pre-Open Losers, Pre-Open Winners, Pre Market Movers, H.C. Wainwright, FDA